Why the Pharmaceutical Industry is Booming in Japan - SPONSOR CONTENT FROM THE GOVERNMENT OF JAPAN

Harvard Business Review

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.

It’s Time to Rein in Exorbitant Pharmaceutical Prices

Harvard Business Review

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. There are compelling reasons, however, to consider doing so for pharmaceuticals.

Why do some companies achieve exceptional performance while so many others struggle to survive?

First Friday Book Synopsis

Bob''s blog entries Abercrombie & Fitch in retail Better before cheaper: Compete on differentiators other than price Deloitte Heartland Express in trucking Maytag in appliances Merck in the pharmaceutical industry Michael E. In search of an answer that could be supported with empirical proof, Michael E. Raynor and Mumtaz Ahmed, along with their team of researchers at Deloitte, embarked on a daunting quest.

Frank Moss: An interview by Bob Morris

First Friday Book Synopsis

Bob's blog entries (MD) Apollo Computer Baltimore Bluefin Labs Bowstreet Cincinnati Children’s Hospital Frank Moss Haifa IBM Infinity Pharmaceuticals Lotus Development MIT University Princeton University the Mayo Clinic the MIT Media Lab the Practice of New Media Medicine The Sorcerers and Their Apprentices: How the Digital Magicians of the MIT Media Lab Are Creating the Innovative Technologies That Will Transform Our Lives Tivoli Systems Stellar Computer Twitter

Value Migration: A book review by Bob Morris

First Friday Book Synopsis

Value Migration: How to Think Several Moves Ahead of the Competition Adrian J. Slywotzky Harvard Business Press (1995) Note: I recently re-read this book before beginning to formulate questions for an interview of Skywotsky. With all due respect to current business bestsellers, none offers more and better insights of immediate and substantial value. Mastering an [.].

Price Gouging and the Dangerous New Breed of Pharma Companies

Harvard Business Review

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver.

How Pharma Can Offer More than Pills

Harvard Business Review

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources.

Research: Innovation Suffers When Drug Companies Merge

Harvard Business Review

This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Therefore, pharmaceutical mergers seem to substantially reduce innovation activities in the relevant market as a whole.

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business Review

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain.

How Pharma Companies Game the System to Keep Drugs Expensive

Harvard Business Review

The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. ” By selling a drug they’re already making under a different name, pharmaceutical firms are effectively extending their monopoly for another six months. Another way pharmaceutical firms are thwarting generics is by restricting access to samples for testing. Regulation Branding Manufacturing Pharmaceuticals Digital Article

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

In some states, accepting a cup of coffee from a pharmaceutical company must be reported, so “education” over lavish meals or in resort settings has largely receded. Guided by a refreshed ethical framework, pharmaceutical companies, in partnership with researchers and clinicians, can help accelerate the spread of knowledge of new clinical science, which now is notoriously slow. Ethics Research & development Government Healthcare Pharmaceuticals Digital Article

The Promise and Challenge of Big Data for Pharma

Harvard Business Review

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. The pharmaceuticals industry has seen an explosion in the amount of available data beyond that collected from traditional, tightly controlled clinical trial environments. Analytics Data Research & development Healthcare Pharmaceuticals Digital Article

What Cancer Researchers Can Learn from Direct-to-Consumer Companies

Harvard Business Review

Organizations collecting patient data — including academic medical centers, foundations that sponsor cancer research, and pharmaceutical companies — must first identify the needs, pains, hopes, expectations, and behaviors of each person living with cancer. Marketing Research & development Social platforms Non-profit Healthcare Pharmaceuticals Digital Article

5 Business Opportunities To Consider In The Healthcare Industry

Strategy Driven

Pharmaceutical Manufacturing. And that direction could be towards pharmaceutical manufacturing. Photo courtesy of Pexels. When you’re trying to come up with the right idea for your future business, you’re likely to find yourself faced with a range of different options.

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

An Exercise to Get Your Team Thinking Differently About the Future

Harvard Business Review

Here are a few of the provocative ideas the group advanced: Pharmaceutical and biotech firms will make smaller bets, and more of them. Innovation National competitiveness Education Healthcare Pharmaceuticals North America

A New Approach to Safely Sharing Cancer Patients’ Data

Harvard Business Review

Shared value Research & development Collaboration Healthcare Pharmaceuticals Digital ArticleIt is well understood that achieving the full potential of precision medicine for all cancer patients depends on the sharing of patients’ genomic and molecular data and clinical information.

Clive Wilson on how to design a purposeful organisation: Part 1 of an interview by Bob Morris

First Friday Book Synopsis

Primeast works primarily in the oil and gas, power, pharmaceutical and […]. Clive Wilson is a writer, speaker, facilitator and business coach. He is a director of Primeast, a learning and development company based in the beautiful town of Harrogate in the county of North Yorkshire in the United Kingdom, some 220 miles north of London.

How To Be A More Effective Work-From-Home Employee

Eric Jacobson

More than 40 million people -- roughly one-third of the U.S. workforce -- work from home at least one or two days a week. If you are a leader of work-from-home employees, share the book, There's No Place Like Working From Home , with them.

Quinn 130

Joseph Jimenez (Novartis) in “The Corner Office”

First Friday Book Synopsis

of Novartis, the pharmaceutical maker. Adam Bryant conducts interviews of senior-level executives that appear in his “Corner Office” column each week in the SundayBusiness section of The New York Times. Here are a few insights provided during an interview of Joseph Jimenez, C.E.O. He says he learned in a previous job that you can’t solve [.]. Bob's blog entries Adam Bryant Corner Office column Joseph Jimenez Marilynn K.

There's No Place Like Working From Home

Eric Jacobson

About 42 million people -- roughly one-third of the U.S. workforce -- work from home at least one or two days a week. If you are a leader of work-from-home employees, share the book, There''s No Place Like Working From Home , with them.

Quinn 130

A Prescription For Empowering Employees To Succeed And Grow

Tanveer Naseer

When I was 18 years old, my uncle got me a job working in the warehouse of a pharmaceutical dispensary near his house in the Toronto suburbs.

What Will Your Leadership Legacy Be?

Eric Jacobson

In its heyday, Marion had 3,400 employees with sales of nearly $1 billion and in 1989 merged with Merrell Dow Pharmaceuticals. As a leader, you likely have asked yourself, " How do I want to be remembered as a leader ?"

Shame On Our Apology Economy

Lead Change Blog

Valeant/Philidor pharmaceutical companies. And this list doesn’t include those who really didn’t apologize like Sepp Blatter, former FIFA president; Martin Shkreli, former CEO, Turing Pharmaceuticals; or recently ousted Pennsylvania Attorney General Kathleen Kane).

The One Meeting that Reliably Produces Huge Consulting Projects

David A Fields

There were about fifteen of us—three from my team and a dozen client personnel—in a conference room at the headquarters of one of the world’s largest pharmaceutical companies.

Veterans Among the Best Civilian Leaders

Strategy Driven

Without this kind of conditioning, recruiters are likely to overlook a veteran candidate when they see, for example, three years of military service instead of three years of pharmaceutical experience on their resume.

The One Important Thing They Never Tell You About Before You Start Leading

Terry Starbucker

Before too long we’re popping aspirin, antacids and other pharmaceuticals to dampen the symptoms so we can just press on and keep working.

Stress 175

A Message to Mylan’s CEO: Your Price Increase Wasn’t the Problem. Your Implementation Strategy Was.

The Kini Group

Is Mylan doing anything different from what other pharmaceutical companies have been doing for decades? That may sound like quite a price hike every six months, but in the world of pharmaceutical drugs this pricing practice is not uncommon.

Price 59

The Mylan EpiPen Debacle: How Tremendous Greed Can Lead to the Demise of a Leader

N2Growth Blog

As you have likely heard, the pharmaceutical company Mylan and its CEO, Heather Bresch, have come under immense scrutiny for the firm’s EpiPen pricing policy. ” “The reality is and the brand pharmaceutical market, this isn’t an EpiPen issue.

Price 130

Don’t Coach Integrity Violations – Fire Them!

Marshall Goldsmith

For example, a pharmaceutical company called me recently. A very wise leader, Alan Mulally, the former CEO of Ford and Fortune’s #3 greatest leader in the world 2013, once told me, “The key to your success is having great customers. If you have a great customer, your process will always work.

New Book For Work-From-Home Employees

Eric Jacobson

About 42 million people -- roughly one-third of the U.S. workforce -- work from home at least one or two days a week. If you are a leader of work-from-home employees, share the new book, There's No Place Like Working From Home , with them.

Quinn 130

Your Leadership Mission Should Fit on a T-Shirt!

Marshall Goldsmith

Not long ago, a pharmaceutical company called me up, and said, “We want you to coach Dr. X.” My mission is simple. It is to: Help successful leaders achieve positive, lasting change in their behavior.

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries.

Starting Thought: Leadership in 2016


Before that, there was money laundering at Enron, fraudulent accounting at WorldCom, securities fraud at Tyco, ethics and compliance violations throughout the pharmaceutical industry, and countless stories of executives inflating their resumes to present a more impressive public face.

Top 25 Companies for Pay and Perks (USA Today)

Chart Your Course

Pharmaceutical and biotechnology make up the second-largest group with three representatives: Genentech, Amgen and Pfizer. The top 25 companies for pay and perks. Casey Kelly-Barton, The Motley Fool. Source: USA Today.

Don’t Forget to Connect Customer Service Week with Strategy

Strategy Driven

Stafford works with pharmaceutical, healthcare, food, consumer packaged goods and beauty care companies – ensuring their customer service initiatives are aligned to their marketing programs so they intrinsically support each other.

John Medina: An interview by Bob Morris

First Friday Book Synopsis

He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health. John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders.

Five Secrets Fulfilled People Use Everyday

Strategy Driven

One out-of-work pharmaceutical executive told me that the only time he networks is when he is out of work, lamenting that he has not learned from past mistakes. Are there real tricks to becoming fulfilled in life? You bet.

Modelling and encouraging a culture of thoughtfulness


was young and inexperienced when I became responsible for overseeing the administration of cardiovascular drug clinical trials for a major pharmaceutical corporation.

The CEO of Merck on Race, Leadership, and High Drug Prices

Harvard Business Review

Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices. Download this podcast.